EUVIMEDEUVIMED entdecken
Crossref

Impact of Genetic Diversity of PCSK9 Polymorphisms on Coronary Artery Disease in a Sample of Iraqi Individuals

Ruaa Heyder Hadi, Majid Kadhum Hussain

Wiadomości Lekarskie · 30.01.2026 · (1) · 69-77

DOI: 10.36740/wlek/216770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wiadomości Lekarskie, online erschienen am 30.01.2026. Verfasst von Ruaa Heyder Hadi und 1 weiteren Autor:innen. Beteiligte Einrichtung: DEPARTMENT OF BIOCHEMISTRY, COLLEGE OF MEDICINE, UNIVERSITY OF KUFA, NAJAF, IRAQ. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Polymorphism, Single Nucleotide, Coronary Artery Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Aim: To assess the association of PCSK9 SNPs (rs2483205, rs2479394) with CAD susceptibility in an Iraqi population. Material and methods Materials and Methods: A case-control study recruited 110 CAD patients, angiographically confirmed, and 110 age-/sex-matched healthy controls. Serum PCSK9 was quantified by ELISA, and lipid profiles were analyzed enzymatically. Genotyping for rs2483205 (C/T) and rs2479394 (G/A) was performed using ARMS-PCR. Associations were evaluated using logistic regression, adjusting for age and sex, haplotype analysis, and genotype-phenotype correlations.

Results

Results: CAD patients exhibited significantly higher PCSK9 levels (54.12 ± 19.04 vs. 20.94 ± 17.72 ng/mL, *p* < 0.0001), LDL-C, TG, and lower HDL-C (p ≤ 0.005) versus controls. Genotype analysis revealed a significant protective effect of the rs2479394 G/A genotype against CAD (OR = 0.21, 95% CI: 0.04–1.08, *p* = 0.024). The rs2483205 SNP showed no significant association. Haplotype analysis identified four major haplotypes; T-A demonstrated significant protection (OR = 0.45, 95% CI: 0.21–0.88, p = 0.020). No significant associations were found between rs2479394 genotypes and phenotypic parameters (blood pressure, lipids, PCSK9) in CAD patients.

Conclusions

Conclusion: The rs2479394 G/A genotype and T-A haplotype are associated with reduced CAD risk in Iraqis, suggesting a protective role for specific PCSK9 variants. Elevated serum PCSK9 and dyslipidemia were confirmed in CAD patients, but rs2479394 did not correlate with these phenotypic traits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proprotein Convertase 9Polymorphism, Single NucleotideCoronary Artery DiseaseHumansMaleIraqFemaleCase-Control StudiesMiddle AgedGenetic Predisposition to DiseaseHaplotypesAdult

Stichwörter der Autor:innen

ARMS-PCRCADPCSK9associationrs2479394rs2483205

Substanzen

Proprotein Convertase 9PCSK9 protein, human

Autor:innen und Institutionen

  • DEPARTMENT OF BIOCHEMISTRY, COLLEGE OF MEDICINE, UNIVERSITY OF KUFA, NAJAF, IRAQ.

Zitieren

APA

Hadi, R. H., & Hussain, M. K. (2026). Impact of Genetic Diversity of PCSK9 Polymorphisms on Coronary Artery Disease in a Sample of Iraqi Individuals. Wiadomości Lekarskie, 69-77. https://doi.org/10.36740/wlek/216770

Vancouver

Hadi RH, Hussain MK. Impact of Genetic Diversity of PCSK9 Polymorphisms on Coronary Artery Disease in a Sample of Iraqi Individuals. Wiadomości Lekarskie. 2026:69-77. doi:10.36740/wlek/216770

BibTeX
@article{Hadi2026,
  author = {Hadi, Ruaa Heyder and Hussain, Majid Kadhum},
  title = {Impact of Genetic Diversity of PCSK9 Polymorphisms on Coronary Artery Disease in a Sample of Iraqi Individuals},
  journal = {Wiadomości Lekarskie},
  year = {2026},
  number = {1},
  pages = {69--77},
  doi = {10.36740/wlek/216770}
}
Kostenlos starten →